Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1970 1
1971 1
1975 4
1976 4
1977 1
1978 1
1979 1
1980 2
1981 4
1982 2
1983 2
1984 3
1985 3
1986 2
1987 4
1988 3
1989 3
1990 2
1991 1
1992 3
1993 3
1994 6
1995 5
1996 8
1997 10
1998 2
1999 8
2000 11
2001 8
2002 5
2003 8
2004 6
2005 10
2006 5
2007 4
2008 10
2009 6
2010 6
2011 11
2012 11
2013 8
2014 7
2015 11
2016 5
2017 10
2018 8
2019 10
2020 18
2021 14
2022 18
2023 23
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

302 results

Results by year

Filters applied: . Clear all
Page 1
The immunology of PF4 polyanion interactions.
Ngo ATP, Bochenek V, Gollomp K. Ngo ATP, et al. Curr Opin Hematol. 2023 Nov 1;30(6):219-229. doi: 10.1097/MOH.0000000000000782. Epub 2023 Aug 28. Curr Opin Hematol. 2023. PMID: 37603711 Review.
This review will outline the different mechanisms through which PF4 engagement with polyanions combats infection but also contributes to the pathogenesis of inflammatory and thrombotic disease states. RECENT FINDINGS: Recent work has shown that PF4 binding to microb …
This review will outline the different mechanisms through which PF4 engagement with polyanions combats infection but also contributes to the …
Behcet's Syndrome.
Dalvi SR, Yildirim R, Yazici Y. Dalvi SR, et al. Drugs. 2012 Dec 3;72(17):2223-41. doi: 10.2165/11641370-000000000-00000. Drugs. 2012. PMID: 23153327 Review.
We discuss strategies to assess and stratify patients based on clinical manifestations and disease severity. A summary of drug toxicities as they relate to the aforementioned pharmacological agents, as well as guidelines regarding vaccinations in this patient population, a …
We discuss strategies to assess and stratify patients based on clinical manifestations and disease severity. A summary of drug toxici …
Thrombotic triad in microgravity.
Elahi MM, Witt AN, Pryzdial ELG, McBeth PB. Elahi MM, et al. Thromb Res. 2024 Jan;233:82-87. doi: 10.1016/j.thromres.2023.11.020. Epub 2023 Nov 22. Thromb Res. 2024. PMID: 38029549 Review.
Thrombotic disease may be an underdiagnosed condition of prolonged exposure to microgravity and yet the underlying factors remain poorly defined. ...In this article, the related literature on thrombotic disease in space is reviewed, with consideration …
Thrombotic disease may be an underdiagnosed condition of prolonged exposure to microgravity and yet the underlying factors rem …
SVEP1 is an endogenous ligand for the orphan receptor PEAR1.
Elenbaas JS, Pudupakkam U, Ashworth KJ, Kang CJ, Patel V, Santana K, Jung IH, Lee PC, Burks KH, Amrute JM, Mecham RP, Halabi CM, Alisio A, Di Paola J, Stitziel NO. Elenbaas JS, et al. Nat Commun. 2023 Feb 15;14(1):850. doi: 10.1038/s41467-023-36486-0. Nat Commun. 2023. PMID: 36792666 Free PMC article.
SVEP1 and PEAR1 causally and concordantly relate to platelet phenotypes and cardiovascular disease in humans, as determined by Mendelian Randomization. Targeting this receptor-ligand interaction may be a viable therapeutic strategy to treat or prevent cardiovascular and …
SVEP1 and PEAR1 causally and concordantly relate to platelet phenotypes and cardiovascular disease in humans, as determined by Mendelian …
Hyperhomocysteinaemia.
Perry DJ. Perry DJ. Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):451-77. doi: 10.1053/beha.1999.0036. Baillieres Best Pract Res Clin Haematol. 1999. PMID: 10856981 Review.
In contrast, moderate hyperhomocysteinaemia is associated with an increased risk of both arterial and venous thrombotic disease but no other abnormalities. This increased risk appears to be independent of other conventional risk factors. ...
In contrast, moderate hyperhomocysteinaemia is associated with an increased risk of both arterial and venous thrombotic disease …
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, Guo Y, Sriratanasathavorn C, Oh S, Okumura K, Lip GYH. Chao TF, et al. Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13. Thromb Haemost. 2022. PMID: 34773920 Free PMC article.
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 which provided useful clinical guidance for cardiologists, neurologists, geriatricians, and general practitioners in the Asia-Pacific …
The consensus of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation (AF) has been published in 2017 w …
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
Cohen H, Sayar Z, Efthymiou M, Gaspar P, Richards T, Isenberg D. Cohen H, et al. Lancet Haematol. 2020 Aug;7(8):e613-e623. doi: 10.1016/S2352-3026(20)30116-2. Lancet Haematol. 2020. PMID: 32735839 Review.
Anticoagulant-refractory thrombotic antiphospholipid syndrome can be broadly defined as breakthrough thrombosis while on standard oral anticoagulation treatment and its management is a major challenge given the serious nature of the thrombotic disease observed, whic …
Anticoagulant-refractory thrombotic antiphospholipid syndrome can be broadly defined as breakthrough thrombosis while on standard oral antic …
Ultrasound and thrombolysis.
Francis CW, Suchkova VN. Francis CW, et al. Vasc Med. 2001;6(3):181-7. doi: 10.1177/1358836x0100600309. Vasc Med. 2001. PMID: 11789973 Review.
Thrombolytic therapy and mechanical interventions are frequently used in the treatment of both arterial and venous thrombotic disease. Limitations to these approaches include failure to achieve reperfusion and complications including bleeding and vessel wall damage. …
Thrombolytic therapy and mechanical interventions are frequently used in the treatment of both arterial and venous thrombotic dise …
Management of incidental pulmonary embolism.
Klok FA, Huisman MV. Klok FA, et al. Eur Respir J. 2017 Jun 29;49(6):1700275. doi: 10.1183/13993003.00275-2017. Print 2017 Jun. Eur Respir J. 2017. PMID: 28663318 Free article. Review.
Even so, observational studies suggest that the natural course of incidental PE is similar to that of symptomatic PE with regard to the risk of recurrent venous thrombotic disease and mortality. Interestingly, the increased use of more advanced CT technology has coi …
Even so, observational studies suggest that the natural course of incidental PE is similar to that of symptomatic PE with regard to the risk …
302 results